Literature DB >> 24309411

A qualitative study of causes of prescribing errors among junior medical doctors in a Nigeria in-patient setting.

Adetutu A Ajemigbitse1, Moses K Omole, Ogugua F Osi-Ogbu, Wilson O Erhun.   

Abstract

AIMS: The aims of this study were to identify and understand the factors underlying prescribing errors in order to determine how to prevent them.
MATERIALS AND METHODS: A prospective qualitative study that involved face-to-face interviews and human factor analysis in a Tertiary Referral Hospital in Central Nigeria, from July 2011 to December 2011. Pharmacists in the study hospital prospectively reviewed prescription orders generated by doctors in selected wards (male and female medical, pediatric and the private wing wards) and identified prescribing errors. The 22 prescribers involved in the errors were interviewed, and given questionnaires to discover factors causing the errors. A model of human error theory was used to analyze the responses.
RESULTS: Responses from the doctors suggest that most errors were made because of slips in attention. Lack of drug knowledge was not the single causative factor in any incident. Risk factors identified included individual, team, environment, and task factors. Junior doctors were affected by the prescribing habits of their seniors. Organizational factors identified included inadequate training/experience, absence of reference materials and absence of self-awareness of errors. Defenses against error such as other clinicians and guidelines were absent or deficient, and supervision was inadequate.
CONCLUSIONS: To reduce the risk of prescribing errors, a number of strategies addressing individual, task, team, and environmental factors such as training of junior doctors, enforcing good practice in prescription writing, supervision, and reviewing the workload of junior doctors must be established.

Entities:  

Mesh:

Year:  2013        PMID: 24309411     DOI: 10.4103/1596-3519.122691

Source DB:  PubMed          Journal:  Ann Afr Med        ISSN: 0975-5764


  8 in total

1.  Associations of physicians' prescribing experience, work hours, and workload with prescription errors.

Authors:  Ilona Leviatan; Bernice Oberman; Eyal Zimlichman; Gideon Y Stein
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

2.  Potential adverse drug events and its predictors among hospitalized patients at medical center in Ethiopia: a prospective observational study.

Authors:  Tamiru Sahilu; Mestawet Getachew; Tsegaye Melaku; Tadesse Sheleme; Duresa Abu; Tesfu Zewdu
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

3.  Confidence in Antibiotic Prescribing Intentions among Senior Medical Students in India.

Authors:  Olivia Ritchie; Veena Shetty; Sumathi Prabhu; Avinash K Shetty
Journal:  Am J Trop Med Hyg       Date:  2020-09-03       Impact factor: 3.707

4.  Why are chemotherapy administration errors not reported? Perceptions of oncology nurses in a Nigerian tertiary health institution.

Authors:  Chinomso Ugochukwu Nwozichi
Journal:  Asia Pac J Oncol Nurs       Date:  2015 Jan-Mar

5.  Antimicrobial knowledge and confidence amongst final year medical students in Australia.

Authors:  Naomi Weier; Karin Thursky; Syed Tabish R Zaidi
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

6.  Effect of providing feedback and prescribing education on prescription writing: An intervention study.

Authors:  Adetutu A Ajemigbitse; Moses Kayode Omole; Wilson O Erhun
Journal:  Ann Afr Med       Date:  2016 Jan-Mar

Review 7.  Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review.

Authors:  Alemayehu B Mekonnen; Tariq M Alhawassi; Andrew J McLachlan; Jo-Anne E Brien
Journal:  Drugs Real World Outcomes       Date:  2018-03

Review 8.  Social and professional influences on antimicrobial prescribing for doctors-in-training: a realist review.

Authors:  Chrysanthi Papoutsi; Karen Mattick; Mark Pearson; Nicola Brennan; Simon Briscoe; Geoff Wong
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.